Missing/wrong data?
Log in to edit
Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial
scientific article
Author/s
author: Julien Taïeb, Philippe Debourdeau, Jean-Baptiste Bachet, Pascal Hammel, Thierry André
Work details
Publication date
February 28, 2017
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.